In patients with MASH, older age, higher anthropometric measurements, comorbidities, elevated plasma levels of FGF21 and lower adiponectin levels were evident (Supplementary Table S2). Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.